Report Detail

Pharma & Healthcare Global Nifedipine Market Professional Survey Report 2019

  • RnM3799799
  • |
  • 02 October, 2019
  • |
  • Global
  • |
  • 104 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Nifedipine is a drug that belongs to the class of calcium channel blocker, which interrupts the movement of calcium in the walls of the arteries. 

The global Nifedipine market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Nifedipine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nifedipine market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Nifedipine in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Nifedipine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Bayer (Germany)
Actavis (USA)
Teva (Israel)
Pfizer (USA)
Shyndec (China)
Honglin (China)
Huanghai (China)
Yabao (China)

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Nifedipine Controlled Release Tablets
Nifedipine Extended Action Tablets

Segment by Application
Primary Pulmonary Hypertension
Heart Failure
Others


Table of Contents

    Executive Summary

      1 Industry Overview of Nifedipine

      • 1.1 Definition of Nifedipine
      • 1.2 Nifedipine Segment by Type
        • 1.2.1 Global Nifedipine Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Nifedipine Controlled Release Tablets
        • 1.2.3 Nifedipine Extended Action Tablets
      • 1.3 Nifedipine Segment by Applications
        • 1.3.1 Global Nifedipine Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Primary Pulmonary Hypertension
        • 1.3.3 Heart Failure
        • 1.3.4 Others
      • 1.4 Global Nifedipine Overall Market
        • 1.4.1 Global Nifedipine Revenue (2014-2025)
        • 1.4.2 Global Nifedipine Production (2014-2025)
        • 1.4.3 North America Nifedipine Status and Prospect (2014-2025)
        • 1.4.4 Europe Nifedipine Status and Prospect (2014-2025)
        • 1.4.5 China Nifedipine Status and Prospect (2014-2025)
        • 1.4.6 Japan Nifedipine Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Nifedipine Status and Prospect (2014-2025)
        • 1.4.8 India Nifedipine Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Nifedipine
      • 2.3 Manufacturing Process Analysis of Nifedipine
      • 2.4 Industry Chain Structure of Nifedipine

      3 Development and Manufacturing Plants Analysis of Nifedipine

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Nifedipine Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Nifedipine
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Nifedipine Production and Capacity Analysis
      • 4.2 Nifedipine Revenue Analysis
      • 4.3 Nifedipine Price Analysis
      • 4.4 Market Concentration Degree

      5 Nifedipine Regional Market Analysis

      • 5.1 Nifedipine Production by Regions
        • 5.1.1 Global Nifedipine Production by Regions
        • 5.1.2 Global Nifedipine Revenue by Regions
      • 5.2 Nifedipine Consumption by Regions
      • 5.3 North America Nifedipine Market Analysis
        • 5.3.1 North America Nifedipine Production
        • 5.3.2 North America Nifedipine Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Nifedipine Import and Export
      • 5.4 Europe Nifedipine Market Analysis
        • 5.4.1 Europe Nifedipine Production
        • 5.4.2 Europe Nifedipine Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Nifedipine Import and Export
      • 5.5 China Nifedipine Market Analysis
        • 5.5.1 China Nifedipine Production
        • 5.5.2 China Nifedipine Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Nifedipine Import and Export
      • 5.6 Japan Nifedipine Market Analysis
        • 5.6.1 Japan Nifedipine Production
        • 5.6.2 Japan Nifedipine Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Nifedipine Import and Export
      • 5.7 Southeast Asia Nifedipine Market Analysis
        • 5.7.1 Southeast Asia Nifedipine Production
        • 5.7.2 Southeast Asia Nifedipine Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Nifedipine Import and Export
      • 5.8 India Nifedipine Market Analysis
        • 5.8.1 India Nifedipine Production
        • 5.8.2 India Nifedipine Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Nifedipine Import and Export

      6 Nifedipine Segment Market Analysis (by Type)

      • 6.1 Global Nifedipine Production by Type
      • 6.2 Global Nifedipine Revenue by Type
      • 6.3 Nifedipine Price by Type

      7 Nifedipine Segment Market Analysis (by Application)

      • 7.1 Global Nifedipine Consumption by Application
      • 7.2 Global Nifedipine Consumption Market Share by Application (2014-2019)

      8 Nifedipine Major Manufacturers Analysis

      • 8.1 Bayer (Germany)
        • 8.1.1 Bayer (Germany) Nifedipine Production Sites and Area Served
        • 8.1.2 Bayer (Germany) Product Introduction, Application and Specification
        • 8.1.3 Bayer (Germany) Nifedipine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Actavis (USA)
        • 8.2.1 Actavis (USA) Nifedipine Production Sites and Area Served
        • 8.2.2 Actavis (USA) Product Introduction, Application and Specification
        • 8.2.3 Actavis (USA) Nifedipine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Teva (Israel)
        • 8.3.1 Teva (Israel) Nifedipine Production Sites and Area Served
        • 8.3.2 Teva (Israel) Product Introduction, Application and Specification
        • 8.3.3 Teva (Israel) Nifedipine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Pfizer (USA)
        • 8.4.1 Pfizer (USA) Nifedipine Production Sites and Area Served
        • 8.4.2 Pfizer (USA) Product Introduction, Application and Specification
        • 8.4.3 Pfizer (USA) Nifedipine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Shyndec (China)
        • 8.5.1 Shyndec (China) Nifedipine Production Sites and Area Served
        • 8.5.2 Shyndec (China) Product Introduction, Application and Specification
        • 8.5.3 Shyndec (China) Nifedipine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Honglin (China)
        • 8.6.1 Honglin (China) Nifedipine Production Sites and Area Served
        • 8.6.2 Honglin (China) Product Introduction, Application and Specification
        • 8.6.3 Honglin (China) Nifedipine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Huanghai (China)
        • 8.7.1 Huanghai (China) Nifedipine Production Sites and Area Served
        • 8.7.2 Huanghai (China) Product Introduction, Application and Specification
        • 8.7.3 Huanghai (China) Nifedipine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Yabao (China)
        • 8.8.1 Yabao (China) Nifedipine Production Sites and Area Served
        • 8.8.2 Yabao (China) Product Introduction, Application and Specification
        • 8.8.3 Yabao (China) Nifedipine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served

      9 Development Trend of Analysis of Nifedipine Market

      • 9.1 Global Nifedipine Market Trend Analysis
        • 9.1.1 Global Nifedipine Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Nifedipine Regional Market Trend
        • 9.2.1 North America Nifedipine Forecast 2019-2025
        • 9.2.2 Europe Nifedipine Forecast 2019-2025
        • 9.2.3 China Nifedipine Forecast 2019-2025
        • 9.2.4 Japan Nifedipine Forecast 2019-2025
        • 9.2.5 Southeast Asia Nifedipine Forecast 2019-2025
        • 9.2.6 India Nifedipine Forecast 2019-2025
      • 9.3 Nifedipine Market Trend (Product Type)
      • 9.4 Nifedipine Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Nifedipine Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Nifedipine. Industry analysis & Market Report on Nifedipine is a syndicated market report, published as Global Nifedipine Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Nifedipine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,789.50
        4,184.25
        5,579.00
        3,244.50
        4,866.75
        6,489.00
        546,105.00
        819,157.50
        1,092,210.00
        292,320.00
        438,480.00
        584,640.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report